United Therapeutics Corporation (UTHR): Price and Financial Metrics


United Therapeutics Corporation (UTHR): $263.17

4.46 (+1.72%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add UTHR to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

UTHR POWR Grades

  • Value is the dimension where UTHR ranks best; there it ranks ahead of 93.33% of US stocks.
  • UTHR's strongest trending metric is Growth; it's been moving up over the last 179 days.
  • UTHR's current lowest rank is in the Momentum metric (where it is better than 42.93% of US stocks).

UTHR Stock Summary

  • UTHR has a market capitalization of $11,994,486,984 -- more than approximately 85.37% of US stocks.
  • UTHR's price/sales ratio is 6.45; that's higher than the P/S ratio of 81.76% of US stocks.
  • UTHR's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 17.51% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to UNITED THERAPEUTICS CORP are GPRO, HLIT, BSY, SONO, and JNPR.
  • Visit UTHR's SEC page to see the company's official filings. To visit the company's web site, go to www.unither.com.

UTHR Valuation Summary

  • UTHR's EV/EBIT ratio is 12.4; this is 22.17% higher than that of the median Healthcare stock.
  • UTHR's EV/EBIT ratio has moved up 18.7 over the prior 243 months.

Below are key valuation metrics over time for UTHR.

Stock Date P/S P/B P/E EV/EBIT
UTHR 2023-01-30 6.3 2.6 16.7 12.4
UTHR 2023-01-27 6.4 2.6 16.7 12.5
UTHR 2023-01-26 6.5 2.6 17.0 12.7
UTHR 2023-01-25 6.5 2.7 17.1 12.8
UTHR 2023-01-24 6.4 2.6 16.8 12.5
UTHR 2023-01-23 6.3 2.6 16.7 12.4

UTHR Growth Metrics

    The 4 year cash and equivalents growth rate now stands at -22.04%.
  • Its 2 year price growth rate is now at 72.6%.
  • Its 5 year net cashflow from operations growth rate is now at -15.12%.
UTHR's revenue has moved up $411,200,000 over the prior 33 months.

The table below shows UTHR's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 1,860 848.9 707.4
2022-06-30 1,788.7 775.9 630.8
2022-03-31 1,768.3 797.1 687.4
2021-12-31 1,685.5 598.2 475.8
2021-09-30 1,655.2 549.8 462.4
2021-06-30 1,590.6 615.1 470.9

UTHR's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • UTHR has a Quality Grade of A, ranking ahead of 95.85% of graded US stocks.
  • UTHR's asset turnover comes in at 0.344 -- ranking 133rd of 681 Pharmaceutical Products stocks.
  • NEOG, AMGN, and AERI are the stocks whose asset turnover ratios are most correlated with UTHR.

The table below shows UTHR's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.344 0.925 0.142
2021-03-31 0.337 0.928 0.126
2020-12-31 0.344 0.927 0.167
2020-09-30 0.340 0.928 0.165
2020-06-30 0.354 0.922 0.158
2020-03-31 0.364 0.922 0.199

UTHR Price Target

For more insight on analysts targets of UTHR, see our UTHR price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $231.89 Average Broker Recommendation 1.35 (Strong Buy)

UTHR Stock Price Chart Interactive Chart >

Price chart for UTHR

UTHR Price/Volume Stats

Current price $263.17 52-week high $283.09
Prev. close $258.71 52-week low $158.38
Day low $259.62 Volume 329,300
Day high $263.73 Avg. volume 344,960
50-day MA $270.27 Dividend yield N/A
200-day MA $232.10 Market Cap 11.99B

United Therapeutics Corporation (UTHR) Company Bio


United Therapeutics develops and commercializes products to address the unmet medical needs of patients with chronic and life-threatening conditions worldwide. Its lead product comprises Remodulin, an injection used for the treatment of pulmonary arterial hypertension. The company was founded in 1996 and is based in Silver Spring, Maryland.


UTHR Latest News Stream


Event/Time News Detail
Loading, please wait...

UTHR Latest Social Stream


Loading social stream, please wait...

View Full UTHR Social Stream

Latest UTHR News From Around the Web

Below are the latest news stories about UNITED THERAPEUTICS CORP that investors may wish to consider to help them evaluate UTHR as an investment opportunity.

This Insider Just Sold Shares of United Therapeutics Corp

Related Stocks: UTHR ,

GuruFocus | January 25, 2023

12 Cheap Biotech Stocks To Buy

In this article, we will be taking a look at 12 cheap biotech stocks to buy. To skip our detailed analysis of the biotech sector, you can go directly to see 5 Cheap Biotech Stocks To Buy. The biotechnology sector has been on the rise over the past three decades. Several forecasts expect the sector […]

Yahoo | January 25, 2023

10 Best Healthcare Stocks For Recession

In this article, we will take a look at the 10 best healthcare stocks for recession. You can skip this part and go to 5 Best Healthcare Stocks For Recession. The healthcare sector in 2022 outperformed the market despite several headwinds and a negative macroeconomic backdrop. Data shows that the Health Care Select Sector SPDR exchange-traded […]

Yahoo | January 21, 2023

United Therapeutics (UTHR) Presents At 41st Annual Healthcare Conference - Slideshow (NASDAQ:UTHR)

The following slide deck was published by United Therapeutics Corporation in conjunction with this event.

Seeking Alpha | January 20, 2023

After Plunging -5.18% in 4 Weeks, Here's Why the Trend Might Reverse for United Therapeutics (UTHR)

United Therapeutics (UTHR) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Yahoo | January 19, 2023

Read More 'UTHR' Stories Here

UTHR Price Returns

1-mo N/A
3-mo -0.85%
6-mo 18.73%
1-year 29.66%
3-year 169.45%
5-year 97.41%
YTD -5.37%
2022 28.70%
2021 42.35%
2020 72.33%
2019 -19.12%
2018 -26.39%

Continue Researching UTHR

Want to see what other sources are saying about UNITED THERAPEUTICS Corp's financials and stock price? Try the links below:

UNITED THERAPEUTICS Corp (UTHR) Stock Price | Nasdaq
UNITED THERAPEUTICS Corp (UTHR) Stock Quote, History and News - Yahoo Finance
UNITED THERAPEUTICS Corp (UTHR) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8212 seconds.